Venki Ramakrishnan | |
---|---|
62nd President of the Royal Society | |
In office 1 December 2015 –30 November 2020 | |
Preceded by | Paul Nurse |
Succeeded by | Adrian Smith |
Personal details | |
Born | Venkatraman Ramakrishnan 1952 (age 71–72) Chidambaram,Madras State (now Tamil Nadu),India |
Citizenship |
|
Spouse | Vera Rosenberry (m. 1975) |
Children | 1 [1] |
Parent |
|
Relatives | Lalita Ramakrishnan (sister) |
Residence | United Kingdom |
Website | www2 |
Known for | |
Awards |
|
Academic background | |
Education | |
Alma mater | Ohio University |
Thesis | The Green Function Theory of the Ferroelectric Phase Transition in Potassium Dihydrogen-Phosphate (1976) |
Doctoral advisor | Tomoyasu Tanaka [1] [7] |
Academic work | |
School or tradition | |
Institutions | |
Venkatraman Ramakrishnan (born 1952) is a British-American structural biologist. He shared the 2009 Nobel Prize in Chemistry with Thomas A. Steitz and Ada Yonath for research on the structure and function of ribosomes. [3] [9] [10] [11]
Since 1999,he has worked as a group leader at the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) on the Cambridge Biomedical Campus,UK and is a Fellow of Trinity College,Cambridge. [12] [13] [14] [15] [16] He served as President of the Royal Society from 2015 to 2020. [17]
Ramakrishnan was born in 1952 in Chidambaram in Cuddalore district of Tamil Nadu,India.
His parents,Prof. C. V. Ramakrishnan and Prof. Rajalakshmi Ramakrishnan were both scientists, [18] [19] and his father was head of the department of biochemistry at the Maharaja Sayajirao University of Baroda. [1] [20] At the time of his birth,Ramakrishnan's father was away from India doing postdoctoral research with David E. Green at the University of Wisconsin–Madison in the US. [1] Ramakrishnan's mother obtained a PhD in psychology from McGill University in 1959, [21] completing it in only 18 months,and was mentored,among others,by Donald O. Hebb. [1]
Ramakrishnan has one sibling,his younger sister Lalita Ramakrishnan,who is professor of immunology and infectious diseases at the department of medicine,University of Cambridge, [22] and a member of the National Academy of Sciences. [23]
Ramakrishnan moved to Vadodara (previously also known as Baroda) in Gujarat at the age of three,where he had his entire schooling at the Convent of Jesus and Mary,except for a year and a half (1960–61) which he and his family spent in Adelaide,Australia. Following his pre-science at the Maharaja Sayajirao University of Baroda,he did his undergraduate studies in the same university on a National Science Talent Scholarship,graduating with a Bachelor of Science degree in physics in 1971. [10] At the time,the physics course at Baroda was new,and based in part on the Berkeley Physics Course and The Feynman Lectures on Physics . [1]
Immediately after graduation he moved to the US,where he obtained his Doctor of Philosophy degree in physics from Ohio University in 1976 for research into the ferroelectric phase transition of potassium dihydrogen phosphate (KDP) [24] supervised by Tomoyasu Tanaka. [7] [25] [26] Then he spent two years studying biology as a graduate student at the University of California,San Diego while making a transition from theoretical physics to biology. [27]
Ramakrishnan began work on ribosomes as a postdoctoral fellow with Peter Moore at Yale University. [10] After his post-doctoral fellowship,he initially could not find a faculty position even though he had applied to about 50 universities in the United States. [28] [29]
He continued to work on ribosomes from 1983 to 1995 as a staff scientist at Brookhaven National Laboratory. [8]
In 1995,he moved to the University of Utah as a professor of biochemistry,and in 1999,he moved to his current position at the Medical Research Council Laboratory of Molecular Biology in Cambridge,England,where he had also been a sabbatical visitor during 1991–92 on a Guggenheim Fellowship.[ citation needed ]
In 1999,Ramakrishnan's laboratory published a 5.5 angstrom resolution structure of the 30S subunit. The following year,his laboratory determined the complete molecular structure of the 30S subunit of the ribosome and its complexes with several antibiotics. This was followed by studies that provided structural insights into the mechanism that ensures the fidelity of protein biosynthesis. In 2007,his laboratory determined the atomic structure of the whole ribosome in complex with its tRNA and mRNA ligands. Since 2013,he has used Cryogenic electron microscopy to work primarily on eukaryotic and mitochondrial translation. [30] [31] Ramakrishnan is also known for his past work on histone and chromatin structure.
As of 2019 [update] his most cited papers (according to Google Scholar [32] ) have been published in Nature , [33] [34] [35] Science , [36] [37] and Cell . [38] [39] [40]
Ramakrishnan's term as president of the Royal Society from 2015-2020 was dominated by Brexit and,in his final year,the COVID-19 pandemic and its response. [41] In an interview in July 2018,he said that Britain's decision to leave the European Union was hurting Britain's reputation as a good place to work in science,commenting "It's very hard for the science community to see any advantages in Brexit. They are pretty blunt about that." He saw advantages to both the UK and the EU for Britain to continue to be engaged in Galileo and Euratom,which,unlike the European Medicines Agency,are not EU agencies. [42]
Ramakrishnan argued that a no-deal Brexit would harm science. Ramakrishnan wrote,"A deal on science is in the best interests of Europe as a whole and should not be sacrificed as collateral damage over disagreements on other issues. If we are going to successfully tackle global problems like climate change,human disease and food security,we can't do so in isolation. There is no scenario where trashing our relationships with our closest scientific collaborators in the EU gets us closer to these goals." [43]
Ramakrishnan was elected a Member of the European Molecular Biology Organization in 2002, [44] a Fellow of the Royal Society (FRS) in 2003, [45] and a Member of the U.S. National Academy of Sciences in 2004.
In 2007,Ramakrishnan was awarded the Louis-Jeantet Prize for Medicine [4] and the Datta Lectureship and Medal of the Federation of European Biochemical Societies (FEBS).
Ramakrishnan was awarded the Nobel Prize in Chemistry in 2009,along with Thomas A. Steitz and Ada Yonath. [46] He received India's second highest civilian honor,the Padma Vibhushan,in 2010. [47]
In 2008,Ramakrishnan won the Heatley Medal of the British Biochemical Society,and became a Fellow of Trinity College,Cambridge and a foreign Fellow of the Indian National Science Academy. He has been a member of the German Academy of Sciences Leopoldina and [48] an Honorary Fellow of the Academy of Medical Sciences (Hon FMedSci) since 2010.
He has received honorary degrees from the Maharaja Sayajirao University of Baroda,University of Utah,Ohio University and University of Cambridge. He is also an Honorary Fellow of Trinity College,Cambridge, [49] Somerville College,Oxford, [50] and The Queen's College,Oxford. [51]
Ramakrishnan was knighted in the 2012 New Year Honours for services to molecular biology, [2] but does not generally use the title "Sir". That same year,he was awarded the Sir Hans Krebs Medal by the FEBS. In 2014,he was awarded the XLVI Jiménez-Díaz Prize by the Fundación Conchita Rábago (Spain).
In 2017,Ramakrishnan received the Golden Plate Award of the American Academy of Achievement. [52]
Ramakrishnan was included as one of 25 Greatest Global Living Indians by NDTV Channel,India on 14 December 2013.
His certificate of election to the Royal Society reads:
Ramakrishnan is internationally recognised for determination of the atomic structure of the 30S ribosomal subunit. Earlier he mapped the arrangement of proteins in the 30S subunit by neutron diffraction and solved X-ray structures of individual components and their RNA complexes. Fundamental insights came from his crystallographic studies of the complete 30S subunit. The atomic model included over 1500 bases of RNA and 20 associated proteins. The RNA interactions representing the P-site tRNA and the mRNA binding site were identified and the likely modes of action of many clinically important antibiotics determined. His most recent work goes to the heart of the decoding mechanism showing the 30S subunit complexed with poly-U mRNA and the stem-loop of the cognate phenylalanine tRNA. Anti-codon recognition leaves the "wobble" base free to accommodate certain non-Watson/Crick basepairs, thus providing an atomic description of both codon:anti-codon recognition and "wobble". He has also made substantial contributions to understanding how chromatin is organised, particularly the structure of linker histones and their role in higher order folding. [53]
In 2020, he was elected to the American Philosophical Society [54] and became a board member of The British Library. [55]
Ramakrishnan was made a Member of the Order of Merit (OM) in 2022. [5]
In 1975, Ramakrishnan married Vera Rosenberry, an author and illustrator of children's books. [1] He has a step-daughter, Tanya Kapka, a physician specializing in public health and health-care delivery to under-served communities; and a son, Raman Ramakrishnan, a cellist specializing in chamber music and professor at Bard College in New York State. [56]
Ribosomes are macromolecular machines, found within all cells, that perform biological protein synthesis. Ribosomes link amino acids together in the order specified by the codons of messenger RNA molecules to form polypeptide chains. Ribosomes consist of two major components: the small and large ribosomal subunits. Each subunit consists of one or more ribosomal RNA molecules and many ribosomal proteins. The ribosomes and associated molecules are also known as the translational apparatus.
Ribosomal ribonucleic acid (rRNA) is a type of non-coding RNA which is the primary component of ribosomes, essential to all cells. rRNA is a ribozyme which carries out protein synthesis in ribosomes. Ribosomal RNA is transcribed from ribosomal DNA (rDNA) and then bound to ribosomal proteins to form small and large ribosome subunits. rRNA is the physical and mechanical factor of the ribosome that forces transfer RNA (tRNA) and messenger RNA (mRNA) to process and translate the latter into proteins. Ribosomal RNA is the predominant form of RNA found in most cells; it makes up about 80% of cellular RNA despite never being translated into proteins itself. Ribosomes are composed of approximately 60% rRNA and 40% ribosomal proteins, though this ratio differs between prokaryotes and eukaryotes.
Bacterial translation is the process by which messenger RNA is translated into proteins in bacteria.
The Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) is a research institute in Cambridge, England, involved in the revolution in molecular biology which occurred in the 1950–60s. Since then it has remained a major medical research laboratory at the forefront of scientific discovery, dedicated to improving the understanding of key biological processes at atomic, molecular and cellular levels using multidisciplinary methods, with a focus on using this knowledge to address key issues in human health.
A ribosomal protein is any of the proteins that, in conjunction with rRNA, make up the ribosomal subunits involved in the cellular process of translation. E. coli, other bacteria and Archaea have a 30S small subunit and a 50S large subunit, whereas humans and yeasts have a 40S small subunit and a 60S large subunit. Equivalent subunits are frequently numbered differently between bacteria, Archaea, yeasts and humans.
A bacterial initiation factor (IF) is a protein that stabilizes the initiation complex for polypeptide translation.
The 5S ribosomal RNA is an approximately 120 nucleotide-long ribosomal RNA molecule with a mass of 40 kDa. It is a structural and functional component of the large subunit of the ribosome in all domains of life, with the exception of mitochondrial ribosomes of fungi and animals. The designation 5S refers to the molecule's sedimentation coefficient in an ultracentrifuge, which is measured in Svedberg units (S).
50S is the larger subunit of the 70S ribosome of prokaryotes, i.e. bacteria and archaea. It is the site of inhibition for antibiotics such as macrolides, chloramphenicol, clindamycin, and the pleuromutilins. It includes the 5S ribosomal RNA and 23S ribosomal RNA.
The prokaryotic small ribosomal subunit, or 30S subunit, is the smaller subunit of the 70S ribosome found in prokaryotes. It is a complex of the 16S ribosomal RNA (rRNA) and 19 proteins. This complex is implicated in the binding of transfer RNA to messenger RNA (mRNA). The small subunit is responsible for the binding and the reading of the mRNA during translation. The small subunit, both the rRNA and its proteins, complexes with the large 50S subunit to form the 70S prokaryotic ribosome in prokaryotic cells. This 70S ribosome is then used to translate mRNA into proteins.
Ribosomal particles are denoted according to their sedimentation coefficients in Svedberg units. The 60S subunit is the large subunit of eukaryotic 80S ribosomes, with the other major component being the eukaryotic small ribosomal subunit (40S). It is structurally and functionally related to the 50S subunit of 70S prokaryotic ribosomes. However, the 60S subunit is much larger than the prokaryotic 50S subunit and contains many additional protein segments, as well as ribosomal RNA expansion segments.
EF-G is a prokaryotic elongation factor involved in mRNA translation. As a GTPase, EF-G catalyzes the movement (translocation) of transfer RNA (tRNA) and messenger RNA (mRNA) through the ribosome.
The eukaryotic small ribosomal subunit (40S) is the smaller subunit of the eukaryotic 80S ribosomes, with the other major component being the large ribosomal subunit (60S). The "40S" and "60S" names originate from the convention that ribosomal particles are denoted according to their sedimentation coefficients in Svedberg units. It is structurally and functionally related to the 30S subunit of 70S prokaryotic ribosomes. However, the 40S subunit is much larger than the prokaryotic 30S subunit and contains many additional protein segments, as well as rRNA expansion segments.
Ribosomes are a large and complex molecular machine that catalyzes the synthesis of proteins, referred to as translation. The ribosome selects aminoacylated transfer RNAs (tRNAs) based on the sequence of a protein-encoding messenger RNA (mRNA) and covalently links the amino acids into a polypeptide chain. Ribosomes from all organisms share a highly conserved catalytic center. However, the ribosomes of eukaryotes are much larger than prokaryotic ribosomes and subject to more complex regulation and biogenesis pathways. Eukaryotic ribosomes are also known as 80S ribosomes, referring to their sedimentation coefficients in Svedberg units, because they sediment faster than the prokaryotic (70S) ribosomes. Eukaryotic ribosomes have two unequal subunits, designated small subunit (40S) and large subunit (60S) according to their sedimentation coefficients. Both subunits contain dozens of ribosomal proteins arranged on a scaffold composed of ribosomal RNA (rRNA). The small subunit monitors the complementarity between tRNA anticodon and mRNA, while the large subunit catalyzes peptide bond formation.
Thomas Arthur Steitz was an American biochemist, a Sterling Professor of Molecular Biophysics and Biochemistry at Yale University, and investigator at the Howard Hughes Medical Institute, best known for his pioneering work on the ribosome.
In molecular biology, translation initiation factor IF-3 is one of the three factors required for the initiation of protein biosynthesis in bacteria. IF-3 is thought to function as a fidelity factor during the assembly of the ternary initiation complex which consists of the 30S ribosomal subunit, the initiator tRNA and the messenger RNA. IF-3 is a basic protein that binds to the 30S ribosomal subunit. The chloroplast homolog enhances the poly(A,U,G)-dependent binding of the initiator tRNA to its ribosomal 30s subunits. IF1–IF3 may also perform ribosome recycling.
In molecular biology, the term macromolecular assembly (MA) refers to massive chemical structures such as viruses and non-biologic nanoparticles, cellular organelles and membranes and ribosomes, etc. that are complex mixtures of polypeptide, polynucleotide, polysaccharide or other polymeric macromolecules. They are generally of more than one of these types, and the mixtures are defined spatially, and with regard to their underlying chemical composition and structure. Macromolecules are found in living and nonliving things, and are composed of many hundreds or thousands of atoms held together by covalent bonds; they are often characterized by repeating units. Assemblies of these can likewise be biologic or non-biologic, though the MA term is more commonly applied in biology, and the term supramolecular assembly is more often applied in non-biologic contexts. MAs of macromolecules are held in their defined forms by non-covalent intermolecular interactions, and can be in either non-repeating structures, or in repeating linear, circular, spiral, or other patterns. The process by which MAs are formed has been termed molecular self-assembly, a term especially applied in non-biologic contexts. A wide variety of physical/biophysical, chemical/biochemical, and computational methods exist for the study of MA; given the scale of MAs, efforts to elaborate their composition and structure and discern mechanisms underlying their functions are at the forefront of modern structure science.
Ada E. Yonath is an Israeli crystallographer and Nobel laureate in Chemistry, best known for her pioneering work on the structure of ribosomes. She is the current director of the Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly of the Weizmann Institute of Science.
The mitochondrial ribosome, or mitoribosome, is a protein complex that is active in mitochondria and functions as a riboprotein for translating mitochondrial mRNAs encoded in mtDNA. The mitoribosome is attached to the inner mitochondrial membrane. Mitoribosomes, like cytoplasmic ribosomes, consist of two subunits — large (mt-LSU) and small (mt-SSU). Mitoribosomes consist of several specific proteins and fewer rRNAs. While mitochondrial rRNAs are encoded in the mitochondrial genome, the proteins that make up mitoribosomes are encoded in the nucleus and assembled by cytoplasmic ribosomes before being implanted into the mitochondria.
50S ribosomal protein L25 is a protein that in Escherichia coli is encoded by the rplY gene.
Andrew P. Carter is a British structural biologist who works at the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) in Cambridge, UK. He is known for his work on the microtubule motor dynein.